Eris Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences has submitted a regulatory compliance certificate confirming proper handling of dematerialization requests during Q4 FY26 (January-March 2026). The certificate from RTA MUFG Intime India Private Limited (formerly Link Intime India) confirms that all securities received for dematerialization were duly confirmed or rejected to depositories (NSDL and CDSL), and that security certificates were mutilated and cancelled as required. The depositories were substituted as registered owners in the register of members within prescribed timelines. This is a routine quarterly compliance filing under SEBI regulations.
This is a standard regulatory compliance filing with no direct impact on the company's financials or operations. It confirms proper adherence to SEBI's dematerialization norms and investor protection measures. No action is required from shareholders.